EVOFEM BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
EVOFEM BIOSCIENCES, INC. (EVFM) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 2.00% for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-27.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2024-03-27
- EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2019-03-31 was 2.50%.
- EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2018-09-30 was 2.90%.
- EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2018-06-30 was 2.80%, a 47.37% increase year-over-year.
- EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2017-06-30 was 1.90%.
- EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 2.00%, a 0.00% change from fiscal 2022.
- EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2022 was 2.00%, a 185.71% increase from fiscal 2021.
- EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2021 was 0.70%, a 16.67% increase from fiscal 2020.
- EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2020 was 0.60%, a 66.67% decline from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month as first filed |
|---|---|---|---|---|---|
| 2023-12-31 | 2.00% 10-K · filed 2024-03-27 | ||||
| 2022-12-31 | 2.00% 10-K · filed 2023-04-27 | ||||
| 2021-12-31 | 0.70% 10-K · filed 2023-04-27 | ||||
| 2020-12-31 | 0.60% 10-K · filed 2022-03-10 | ||||
| 2019-12-31 | 1.80% 10-K · filed 2021-03-04 | ||||
| 2019-03-31 | 2.50% 10-Q · filed 2019-05-07 | ||||
| 2018-12-31 | 2.90% 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | 2.90% 10-Q · filed 2018-11-07 | 2.80% 10-Q · filed 2018-11-07 | |||
| 2018-06-30 | 2.80% 10-Q · filed 2018-08-02 | 2.80% 10-Q · filed 2018-08-02 | |||
| 2017-12-31 | 2.20% 10-K · filed 2019-03-01 | 1.74% 10-K · filed 2018-02-26 | |||
| 2017-09-30 | 2.20% 10-Q · filed 2018-11-07 | ||||
| 2017-06-30 | 1.90% 10-Q · filed 2018-08-02 | 2.20% 10-Q · filed 2018-08-02 | |||
| 2017-03-31 | 2.20% 10-Q · filed 2018-05-14 | ||||
| 2016-12-31 | 1.30% 8-K/A · filed 2018-04-06 | 1.61% 10-K · filed 2017-03-23 | |||
| 2015-12-31 | 1.69% 10-K · filed 2018-02-26 | ||||
| 2014-12-31 | 1.85% 10-K · filed 2017-03-23 |